Spinal Cord
Spinal Cord - most related articles:
-
Human clinical trial of embryonic stem cell therapy approved - 8.1
-
Over a million more paralyzed than previously estimated, US - 6.8
-
Clinical trial of human embryonic stem cell therapy in US - 6.6
-
Pain is not a symptom of arthritis, pain causes arthritis - 6.5
-
Allergan's BOTOX will be available in European Countries for Urinary Incontinence - 5.3
-
Christopher & Dana Reeve Foundation Applauds Senate Passage of the Christopher and Dana Reeve Paralysis Act - 4.4
-
HIV virus hides in the brain - 4.2
-
Le Bonheur surgeons separated rare conjoined pygopagus twins - 4.1
-
Early clamping may interrupt humankind's first natural stem cell transplant - 3.6
-
New research will help identify risk factors for SIDS - 3.6
Spinal Cord articles
29 new genetic variants linked to multiple sclerosisScientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of a very debilitating neurological disease. Many of the genes implicated in the study are relevant to the immune system, shedding light onto the immunological pathways that underlie the development of multiple sclerosis.
Allergan's BOTOX will be available in European Countries for Urinary IncontinenceAllergan is pleased to announce that BOTOX (botulinum toxin type A) has received a positive opinion from the Irish Medicines Board for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO) resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis.
Low vitamin D levels seen as multiple sclerosis risk for African AmericansVitamin D levels in the blood are lower in African Americans who have the disease, compared to African Americans who do not, revealed by researchers exploring the connection between vitamin D and multiple sclerosis in African Americans.
GM-CSF required for the immune attack in multiple sclerosisThe neutralization of the cytokine GM-CSF could halt the development of multiple sclerosis, demonstrated by the research team of the immunologist Burkhard Becher at the University of Zurich in an animal model.
Clinical trial of human embryonic stem cell therapy in USGeron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1.
Smoking may increase multiple sclerosis riskSmoking may increase the risk of multiple sclerosis (MS) in people who also have specific established risk factors for MS. The research is found in the April_7, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Ampyra, dalfampridine approved for multiple sclerosis patientsThe U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS).
Smoking increases brain lesions and brain shrinkage in MSPeople who smoke and have multiple sclerosis (MS) may be at increased risk of brain shrinkage and increased brain lesions related to the disease, revealed by researchers.
Smoking leads to rapid progression of multiple sclerosisPatients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease, revealed by researchers in the Archives of Neurology.
UK's MS Society supports Carers WeekNew research launched to mark the start of national Carers Week (8-13 June) shows that almost three-quarters (74%) of carers have reached breaking point due to the pressures of their caring role.
New drug to improve walking ability in multiple sclerosis peopleAcorda Therapeutics, Inc. (Nasdaq: ACOR) announced that the U.S. Food and Drug Administration (FDA) has accepted the Fampridine-SR New Drug Application (NDA) for filing, assigning Priority Review and a Prescription Drug User Fee Act (PDUFA) date of October_22, 2009.
Folic acid may help treat allergies, asthmaFolic acid, or vitamin B9, essential for red blood cell health and long known to reduce the risk of spinal birth defects, may also suppress allergic reactions and lessen the severity of allergy and asthma symptoms, according to new research from the Johns Hopkins Children's Center.
New pill cladribine to treat Multiple sclerosis MSA new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.
Over a million more paralyzed than previously estimated, USA survey of over 33,000 households released shows that 40 percent more Americans live with paralysis and over five times the number of Americans live with spinal cord injury than previously estimated.
Caffeine in males with Lou Gehrig's diseaseAmyotrophic lateral sclerosis (ALS) is a fatal disease that damages key neurons in the brain and spinal cord. The disease causes progressive paralysis of voluntary muscles and often death within five years of symptoms.
Christopher & Dana Reeve Foundation Applauds Senate Passage of the Christopher and Dana Reeve Paralysis ActThe Christopher & Dana Reeve Foundation, the national, non-profit organization dedicated to finding cures and treatments for spinal cord injuries and improving the lives of people living with paralysis, applauds the United States Senate for passing the Christopher and Dana Reeve Paralysis Act (CDRPA).
Human clinical trial of embryonic stem cell therapy approvedGeron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
Pain is not a symptom of arthritis, pain causes arthritisPain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism.
18 Spinal Cord articles listed above.